Huntington National Bank’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $116 | Hold |
1
| – | – | ﹤0.01% | 2580 |
|
|
2025
Q4 | $116 | Hold |
1
| – | – | ﹤0.01% | 2500 |
|
|
2025
Q3 | $116 | Hold |
1
| – | – | ﹤0.01% | 2595 |
|
|
2025
Q2 | $116 | Hold |
1
| – | – | ﹤0.01% | 2647 |
|
|
2025
Q1 | $116 | Hold |
1
| – | – | ﹤0.01% | 2686 |
|
|
2024
Q4 | $116 | Hold |
1
| – | – | ﹤0.01% | 2714 |
|
|
2024
Q3 | $116 | Hold |
1
| – | – | ﹤0.01% | 2706 |
|
|
2024
Q2 | $116 | Hold |
1
| – | – | ﹤0.01% | 2678 |
|
|
2024
Q1 | $116 | Hold |
1
| – | – | ﹤0.01% | 2488 |
|
|
2023
Q4 | $116 | Hold |
1
| – | – | ﹤0.01% | 2405 |
|
|
2023
Q3 | $116 | Sell |
1
-129
| -99% | -$13.9K | ﹤0.01% | 2389 |
|
|
2023
Q2 | $13.4K | Sell |
130
-47
| -27% | -$4.96K | ﹤0.01% | 1481 |
|
|
2023
Q1 | $19.3K | Sell |
177
-74
| -29% | -$8.18K | ﹤0.01% | 1329 |
|
|
2022
Q4 | $28.6K | Sell |
251
-216
| -46% | -$17.9K | ﹤0.01% | 1170 |
|
|
2022
Q3 | $29K | Sell |
467
-652
| -58% | -$45.6K | ﹤0.01% | 1158 |
|
|
2022
Q2 | $89K | Buy |
1,119
+7
| +0.6% | +$663 | ﹤0.01% | 819 |
|
|
2022
Q1 | $117K | Buy |
1,112
+26
| +2% | +$2.53K | ﹤0.01% | 794 |
|
|
2021
Q4 | $117K | Hold |
1,086
| – | – | ﹤0.01% | 813 |
|
|
2021
Q3 | $119K | Buy |
1,086
+503
| +86% | +$52.2K | ﹤0.01% | 716 |
|
|
2021
Q2 | $55K | Buy |
583
+225
| +63% | +$20.7K | ﹤0.01% | 928 |
|
|
2021
Q1 | $33K | Sell |
358
-13
| -4% | -$1.1K | ﹤0.01% | 978 |
|
|
2020
Q4 | $27K | Buy |
371
+72
| +24% | +$5.35K | ﹤0.01% | 1017 |
|
|
2020
Q3 | $23K | Sell |
299
-122
| -29% | -$8.39K | ﹤0.01% | 1012 |
|
|
2020
Q2 | $23K | Sell |
421
-11,468
| -96% | -$491K | ﹤0.01% | 990 |
|
|
2020
Q1 | $352K | Sell |
11,889
-379
| -3% | -$12.8K | 0.01% | 405 |
|
|
2019
Q4 | $444K | Hold |
12,268
| – | – | 0.01% | 412 |
|
|
2019
Q3 | $334K | Sell |
12,268
-2,708
| -18% | -$70K | 0.01% | 439 |
|
|
2019
Q2 | $360K | Hold |
14,976
| – | – | 0.01% | 433 |
|
|
2019
Q1 | $396K | Buy |
14,976
+13,344
| +818% | +$316K | 0.01% | 414 |
|
|
2018
Q4 | $32K | Sell |
1,632
-445
| -21% | -$8.72K | ﹤0.01% | 999 |
|
|
2018
Q3 | $41K | Buy |
+2,077
| New | +$39.5K | ﹤0.01% | 1041 |
|
|
2016
Q4 | – | Sell |
-51
| Closed | – | – | 1564 |
|
|
2016
Q3 | $0 | Buy |
+51
| New | +$996 | ﹤0.01% | 1621 |
|
|
2016
Q2 | – | Sell |
-44
| Closed | -$1K | – | 1760 |
|
|
2016
Q1 | $1K | Buy |
+44
| New | +$770 | ﹤0.01% | 1697 |
|
|
2015
Q3 | – | Sell |
-46
| Closed | -$2K | – | 1834 |
|
|
2015
Q2 | $2K | Buy |
46
+2
| +5% | +$61 | ﹤0.01% | 1718 |
|
|
2015
Q1 | $1K | Buy |
+44
| New | +$807 | ﹤0.01% | 1709 |
|
Huntington National Bank's HZNP Position: Q1 2026 in Review
Huntington National Bank held its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) position steady in Q1 2026 at 1 share worth $116. The position accounts for ﹤0.01% of the portfolio, ranked #2580.
Huntington National Bank first reported a position in HZNP in Q1 2015 and has held it in 35 quarters since. The position peaked at $444K in Q4 2019. 1 fund tracked by Wall St. Rank holds HZNP as of Q1 2026.
- Huntington National Bank held 1 share of Horizon Therapeutics Public Limited Company Ordinary Shares worth $116 as of Q1 2026.
- Huntington National Bank left its Horizon Therapeutics Public Limited Company Ordinary Shares share count unchanged in Q1 2026.
- Horizon Therapeutics Public Limited Company Ordinary Shares made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2580 holding.
- Huntington National Bank first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2015 and has held it in 35 quarters since.
- Huntington National Bank's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $444K in Q4 2019.
- 1 fund tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.